Novozymes A/S (OTCMKTS:NVZMY) Reaches New 12-Month High – Here’s What Happened

Novozymes A/S (OTCMKTS:NVZMY) hit a new 52-week high on Wednesday . The company traded as high as $66.92 and last traded at $66.92, with a volume of 7071 shares changing hands. The stock had previously closed at $64.19.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on NVZMY shares. Kepler Capital Markets upgraded Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Zacks Research upgraded shares of Novozymes A/S from a “strong sell” rating to a “hold” rating in a research report on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy”.

Novozymes A/S Trading Up 4.4%

The firm’s 50-day simple moving average is $63.30 and its 200-day simple moving average is $60.47. The firm has a market capitalization of $27.79 billion, a PE ratio of 45.30, a price-to-earnings-growth ratio of 3.07 and a beta of 0.92. The company has a quick ratio of 1.03, a current ratio of 1.67 and a debt-to-equity ratio of 0.27.

Institutional Investors Weigh In On Novozymes A/S

An institutional investor recently raised its position in Novozymes A/S stock. Elefante Mark B boosted its stake in shares of Novozymes A/S (OTCMKTS:NVZMY) by 73.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,900 shares of the biotechnology company’s stock after acquiring an additional 2,500 shares during the quarter. Elefante Mark B’s holdings in Novozymes A/S were worth $371,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 0.03% of the company’s stock.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).